Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06234124

Characterization and Clinical Trial of a Variable Friction Shoe

Led by Shirley Ryan AbilityLab · Updated on 2026-05-11

50

Participants Needed

1

Research Sites

164 weeks

Total Duration

On this page

Sponsors

S

Shirley Ryan AbilityLab

Lead Sponsor

U

University of California, Santa Barbara

Collaborating Sponsor

AI-Summary

What this Trial Is About

More than one million Americans present with foot drop after stroke. As the aging population grows in the United States and across the world, incidence of stroke will grow as age is a key risk factor, thus there will be a need for low-cost, easy-to-use, and scalable solutions to administer proper therapy to promote recovery. This study will evaluate a Variable Friction shoe (VF shoe), a new low-cost medical device, for foot drop in an at-home setting.

CONDITIONS

Official Title

Characterization and Clinical Trial of a Variable Friction Shoe

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • At least 3 months poststroke
  • Age 18 or older
  • Possess a prescribed AFO or be a potential candidate for use of an AFO
  • Can ambulate at least 10 meters with or without an assistive device such as a cane or walker
  • Medically stable as determined by physician medical clearance
  • No expected change in medications for at least 3 months
  • Adequate stability at the ankle during stance
  • Ability to hear clicking noise made by the VF shoe
  • Physician approval
  • Ability to give informed consent
  • Able to sit unsupported and follow a three-step command
  • No unhealed or unresolved orthopedic injury to upper or lower extremities and no history of severe back pain
  • English speaking
  • Willing to follow an exercise program with both devices for at least 30 minutes per day, at least 5 days per week for 6 months
Not Eligible

You will not qualify if you...

  • History of falling more than once a week prior to the stroke
  • Gait speed (self-selected velocity) greater than 1.2 m/s
  • Inability to operate the devices safely without caregiver assistance
  • Morbid obesity (body mass index greater than 40 kg/m2)
  • Serious cardiac conditions, myocardial infarction, congestive heart failure, demand pacemaker, seizures, excessive dysesthetic pain, or severe lower extremity pathology interfering with device use
  • Severe cognitive or communication deficits
  • Pregnant women (self-reported)
  • Co-morbidities interfering with the study such as significant arthritis, joint problems, back injury, neuromuscular disorders, epilepsy
  • Severe osteoporosis (self-reported)
  • Prisoners
  • Currently receiving botox injections in the lower extremities

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shirley Ryan AbilityLab

Chicago, Illinois, United States, 60611

Actively Recruiting

Loading map...

Research Team

J

Joe Harris, DPT

CONTACT

J

Jennifer Bartloff, DPT, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here